Pegavision Corporation (TPE:6491)
Taiwan · Delayed Price · Currency is TWD 284.50
-2.50 (-0.87%)
Jan 13, 2026, 11:21 AM CST
Pegavision Market Cap
Pegavision has a market cap or net worth of 22.39 billion as of January 12, 2026. Its market cap has decreased by -18.58% in one year.
Market Cap
22.39B
Enterprise Value
19.52B
Revenue
6.90B
Ranking
n/a
PE Ratio
14.08
Stock Price
284.50
Market Cap Chart
Since December 30, 2014, Pegavision's market cap has increased from 9.60B to 22.39B, an increase of 133.19%. That is a compound annual growth rate of 7.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 22.39B | 0.70% |
| Dec 31, 2025 | 22.23B | -24.40% |
| Dec 31, 2024 | 29.41B | -4.92% |
| Dec 29, 2023 | 30.93B | 4.20% |
| Dec 30, 2022 | 29.68B | -0.70% |
| Dec 30, 2021 | 29.89B | 50.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Center Laboratories | 30.53B |